Show
Sort by
-
Cusatuzumab for treatment of CD70-positive relapsed or refractory cutaneous T-cell lymphoma
-
- Journal Article
- A1
- open access
The NHance® mutation-equipped anti-MET antibody ARGX-111 displays increased tissue penetration and anti-tumor activity in advanced cancer patients
-
Uncovering the immune-modulating role of anti-RANKL therapy for cervical cancer : preliminary results
-
Unveiling a CD70-positive subset of cancer-associated fibroblasts marked by pro-migratory activity and thriving regulatory T cell accumulation
-
CD70 and PD-L1 in anaplastic thyroid cancer : promising targets for immunotherapy
-
- Journal Article
- A1
- open access
Preclinical data on the combination of cisplatin and anti-CD70 therapy in non-small cell lung cancer as an excellent match in the era of combination therapy
-
- Journal Article
- A1
- open access
The MDM2-inhibitor Nutlin-3 synergizes with cisplatin to induce p53 dependent tumor cell apoptosis in non-small cell lung cancer